Diatrizoate Meglumine and Diatrizoate Sodium
Active substance: DIATRIZOATE MEGLUMINE, DIATRIZOATE SODIUM
SOLUTION · DIATRIZOATE MEGLUMINE 660 mg/mL, DIATRIZOATE SODIUM 100 mg/mL
United StatesActive
Marketing holder: Camber Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DIATRIZOATE MEGLUMINE · 660 mg/mL
- DIATRIZOATE SODIUM · 100 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12094-1597-772c-b2b0-212766fa51b2,01a1209b-81ca-7a1a-a3eb-e21e91693890;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 31722-019
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL, RECTAL
Sources
- product · openFDA NDC · 31722-019 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 31722-019 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 31722-019 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 31722-019 · Verified 2026-10-09 · open in source